- Home
- MVST vs XBIT Comparison
MVST vs XBIT Comparison
Compare MVST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- XBIT
- Stock Information
- Founded
- MVST 2006
- XBIT 2005
- Country
- MVST United States
- XBIT United States
- Employees
- MVST N/A
- XBIT N/A
- Industry
- MVST Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- MVST Miscellaneous
- XBIT Health Care
- Exchange
- MVST Nasdaq
- XBIT Nasdaq
- Market Cap
- MVST 1.3B
- XBIT 89.6M
- IPO Year
- MVST N/A
- XBIT 2015
- Fundamental
- Price
- MVST $3.61
- XBIT $3.18
- Analyst Decision
- MVST Strong Buy
- XBIT
- Analyst Count
- MVST 1
- XBIT 0
- Target Price
- MVST $3.00
- XBIT N/A
- AVG Volume (30 Days)
- MVST 9.2M
- XBIT 187.9K
- Earning Date
- MVST 08-07-2025
- XBIT 08-11-2025
- Dividend Yield
- MVST N/A
- XBIT N/A
- EPS Growth
- MVST N/A
- XBIT N/A
- EPS
- MVST N/A
- XBIT N/A
- Revenue
- MVST $414,941,000.00
- XBIT N/A
- Revenue This Year
- MVST $26.08
- XBIT N/A
- Revenue Next Year
- MVST $29.71
- XBIT N/A
- P/E Ratio
- MVST N/A
- XBIT N/A
- Revenue Growth
- MVST 21.68
- XBIT N/A
- 52 Week Low
- MVST $0.15
- XBIT $2.50
- 52 Week High
- MVST $4.72
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- MVST 47.09
- XBIT 63.47
- Support Level
- MVST $3.42
- XBIT $2.58
- Resistance Level
- MVST $4.27
- XBIT $3.32
- Average True Range (ATR)
- MVST 0.32
- XBIT 0.17
- MACD
- MVST -0.12
- XBIT 0.07
- Stochastic Oscillator
- MVST 13.85
- XBIT 82.93
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.